ENST00000592604.6:n.3186G>T
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000592604.6(SMARCA4):n.3186G>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000379 in 1,614,008 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
ENST00000592604.6 non_coding_transcript_exon
Scores
Clinical Significance
Conservation
Publications
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SMARCA4 | ENST00000646693.2 | c.*1G>T | 3_prime_UTR_variant | Exon 36 of 36 | NM_001387283.1 | ENSP00000495368.1 | ||||
| SMARCA4 | ENST00000344626.10 | c.*1G>T | 3_prime_UTR_variant | Exon 35 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | |||
| SMARCA4 | ENST00000643549.1 | c.*1G>T | 3_prime_UTR_variant | Exon 35 of 35 | ENSP00000493975.1 | |||||
| SMARCA4 | ENST00000643296.1 | c.*1G>T | 3_prime_UTR_variant | Exon 34 of 34 | ENSP00000496635.1 | |||||
| SMARCA4 | ENST00000644737.1 | c.*1G>T | 3_prime_UTR_variant | Exon 34 of 34 | ENSP00000495548.1 | |||||
| SMARCA4 | ENST00000643995.1 | c.*1G>T | 3_prime_UTR_variant | Exon 32 of 32 | ENSP00000496004.1 | |||||
| SMARCA4 | ENST00000644963.1 | c.*1G>T | 3_prime_UTR_variant | Exon 28 of 28 | ENSP00000495599.1 | |||||
| SMARCA4 | ENST00000644065.1 | c.*1G>T | 3_prime_UTR_variant | Exon 27 of 27 | ENSP00000493615.1 | |||||
| SMARCA4 | ENST00000642350.1 | c.*1G>T | 3_prime_UTR_variant | Exon 27 of 27 | ENSP00000495355.1 | |||||
| SMARCA4 | ENST00000643857.1 | c.*1G>T | 3_prime_UTR_variant | Exon 25 of 25 | ENSP00000494159.1 | |||||
| SMARCA4 | ENST00000538456.4 | c.*1G>T | 3_prime_UTR_variant | Exon 8 of 8 | 3 | ENSP00000495197.1 | ||||
| SMARCA4 | ENST00000541122.6 | c.*1G>T | downstream_gene_variant | 5 | ENSP00000445036.2 | |||||
| SMARCA4 | ENST00000589677.5 | c.*1G>T | downstream_gene_variant | 5 | ENSP00000464778.1 |
Frequencies
GnomAD3 genomes AF: 0.00193 AC: 294AN: 152222Hom.: 4 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000490 AC: 123AN: 251158 AF XY: 0.000346 show subpopulations
GnomAD4 exome AF: 0.000216 AC: 315AN: 1461668Hom.: 3 Cov.: 30 AF XY: 0.000184 AC XY: 134AN XY: 727154 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00195 AC: 297AN: 152340Hom.: 4 Cov.: 32 AF XY: 0.00203 AC XY: 151AN XY: 74512 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:3
- -
This variant is associated with the following publications: (PMID: 24728327) -
SMARCA4: BS1, BS2 -
not specified Benign:2Other:1
- -
- -
- -
Intellectual disability, autosomal dominant 16 Benign:1
- -
Hereditary cancer-predisposing syndrome Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at